Physician profile
Emily N Keller
NPI 1215447602
$3,026.19
in general payments reported to CMS, 2019-2025
12 companies · $1,074 in 2025
The $1,074 reported for 2025 was more than what 82% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,747 · 2024: $205 · 2025: $1,074.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,056 · Travel and Lodging: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,055.94 |
| Travel and Lodging | $223.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,757.73 | 2022-2025 | Eterna |
| Brainlab, INC. | $317.03 | 2025 | Brainlab, INC. |
| Teva Pharmaceuticals USA, INC. | $209.62 | 2025 | Uzedy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.93 | 2025 | Xifaxan |
| Madrigal Pharmaceuticals | $122.21 | 2025 | Rezdiffra |
| Novo Nordisk INC | $117.38 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $115.54 | 2024 | |
| Amgen INC. | $97.64 | 2025 | Evenity |
| Inspire Medical Systems, INC. | $89.37 | 2024 | Inspire |
| Abbvie INC. | $36.55 | 2025 | |
| Globus Medical, INC. | $24.93 | 2025 | Omnia |
| Biohaven Pharmaceutical Holding Company LTD. | $13.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Keller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.